StockGlow

Iovance Biotherapeutics, Inc. (0JDK.L)

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.

$4.26-0.11%
Compare 0JDK.L with
StockGlow Score
6
Bearish
BearishBullish
1 year ago+64.2%

The outlook

Iovance Biotherapeutics, Inc. currently reads as bearish based on below its 50- & 200-day averages, 7% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range7% of the way from its 52-week low to high
Market cap
—
52-wk high
$18.31
52-wk low
$3.22
50-day avg
$11.04
200-day avg
$7.44
Trailing P/E
—

Similar stocks

2LB.FIovance Biotherapeutics, Inc.$3.93-1.01%ENET.LEthernity Networks Ltd.$0.00+16.67%THRU.LThruvision Group plc$0.62-4.31%0JBU.LIntellia Therapeutics, Inc.$10.82-0.92%0ML1.ILEDP Renewables, S.A.$13.42-0.56%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy